Eli Lilly participated in a series B round for the cardiorenal treatment specialist that will support clinical drug trials, boosting its overall funding to $193m.

Allianz Life Ventures contributed to a round that boosted the investment tools provider's overall funding to $120m.

The CRM Platform Fund, formed three years after the unit's inaugural fund, will invest in enterprise software producers from seed to late stage.

Orbia, Koura, Hitachi, JLR, TDK, Doral and Trumpf took part in a second $70m round to be announced by the battery recycling service provider in under a month.

Singtel Innov8 is set to exit cybersecurity technology developer Bitglass in an acquisition deal while Nio Capital contributed to marketing software developer Whale's $50m series B round.

WestCap and Caisse de dépôt et placement du Québec co-led a round valuing the Tether-backed crypto lending platform developer at over $3bn.

SoftBank helped the internet communication software developer secure $300m in a round which brought the company's overall funding to $697m.

The Duchenne muscular dystrophy drug developer's initial public offering could prove an exit ramp for Roche and Merck & Co.

The Lundbeck, Chiesi Group and Li-Cor Biosciences-backed eye and bladder cancer therapeutics developer has filed to go public on Nasdaq in an offering with a $100m placeholder target.

Mobiliar took part in a $35m round for medicine transportation system developer SkyCell while Nice Investment co-led wealth management software provider Fount's $33.4m series C.